This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
19 Mar 2014

Thermo Fisher Scientific Debuts Innovation?s in Bioprocess?ing at INTERPHEX 2014

Thermo Fisher Scientific Inc., the world leader in serving science, has introduced new innovations in cell culture and bioprocessing technologies to address the evolving requirements of biologic drug discovery and production for global biopharmaceutical and pharmaceutical manufacturers. These advancements, including a new high-volume centrifugation system and controller platforms for its next-generation single-use bioreactor, will be showcased this week at INTERPHEX, Jacob Javitz Convention Center, New York City, 18–20 March 2014, Booth #3544.

 

“Thermo Fisher has combined exceptional technologies with a deep understanding of the challenges of bringing biologic pharmaceuticals from discovery to development and production,” said Cory Stevenson, president of the bioprocessing business at Thermo Fisher. “The combination of Thermo Scientific single-use technologies with the cell culture, purification, and analytics capabilities under the Life Technologies brand increases our depth of capabilities so that we can provide our biotechnology and biopharmaceutical customers with integrated solutions. Doing so enhances their efficiency and productivity across the entire bioproduction workflow.”

 

Highlights at INTERPHEX include

• New Thermo Scientific bioreactor controller platforms for the Thermo Scientific single-use systems offer the choice, performance and flexibility. Developed with technology integration partners Applikon and Finesse and under the Thermo Scientific brand, the controllers meet the needs of both highly configurable cGMP and cost-effective research applications.

• New Thermo Scientific Sorvall RC BIOS 10 large-capacity centrifuge offers a new 10-L capacity for batch bioprocessing centrifugation. The system combines the centrifuge with carbon fiber rotors and paperless data collection software, to improve productivity and protects sample safety and integrity.

• Life Technologies products that span the biologics workflow and include a portfolio of premium solutions and services focused on upstream cell culture, downstream purification and analytics for detection and quantitation of process/product impurities and contaminants. Products on display include Life Technologies Gibco cell culture media and feeds in both liquid and AGT Dry Media formats, GoPure Prepacked and POROS A, G and CaptureSelect Chromatography Columns, and MycoSEQ Myccoplasma Detection System.

• The industry-leading Thermo Scientific Aegis5-14 Film, the most advanced film for demanding cell culture and single-use bioprocessing applications.

• The Thermo Scientific HyPerforma Single-Use Bioreactor (SUB), which offers all of the advantages of previous SUBs while offering advancements that make it easier to manage tubing systems and loading of single-use Thermo Scientific bioprocess containers. The SUBs also feature faster heat up and cool down, flexible positioning, and height-adjustable single- or dual-filter brackets.

 

The combination of Thermo Scientific’s single-use and bioprocessing technologies with the cell culture, purification, and analytics business from Life Technologies increases our depth of capabilities so that we can provide our biotechnology and biopharmaceutical customers with integrated solutions across the entire bioproduction workflow.

Related News

  • News Federal judge blocks Colorado's unprecedented price cap on Amgen's Enbrel

    A US federal court has halted Colorado's attempt to impose a US$31,200 annual price cap on Amgen's arthritis drug Enbrel, ruling that the pharmaceutical company would likely suffer irreparable harm. The decision represents a significant blow to...
  • News Protecting life-saving therapies: CPHI Online Podcast Series

    The latest episode of the CPHI Podcast Series dives into a critical challenge facing the pharmaceutical industry: ensuring the integrity of temperature-sensitive medications and biologics through advanced predictive technology.

  • News 2026 Outsourcing Outlook Update - pharma at a crossroads

    The pharmaceutical contract development and manufacturing organisation (CDMO) sector is experiencing unprecedented transformation, driven by evolving therapeutic complexities, geopolitical tensions, and the growing demand for specialised manufacturing ...
  • News Roche maintains German investment commitment whilst rivals scale back

    Pharmaceutical giant Roche has reaffirmed its commitment to investing in Germany, standing firm even as competitors Eli Lilly and Boehringer Ingelheim dramatically reduce their planned investments in response to controversial healthcare reforms.

  • News Women in Pharma: The History of CPHI Women in Japan

    Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.
  • News EU drafts deal to end essential medicines shortage

    European negotiators have agreed new legislation to tackle persistent shortages of essential medicines by prioritising supply security over price in public procurement and supporting domestic pharmaceutical manufacturing with strategic funding.

  • News Thermo Fisher Scientific offloads microbiology business to PE firm Astorg

    The life sciences giant is divesting its global microbiology unit, which generated $645 million in revenue last year, to the pan-European private equity firm as part of an active portfolio management strategy. The transaction is expected to close in th...
  • News The Shift: Why Sustainability is Moving to the Centre of CPHI Milan 2026

    CPHI Online contributor David Roach takes a look at how conversations around sustainability in the pharmaceutical industry can and must be transformed into actionable deliveries, and what the inaugural CPHI Sustainability Summit means for the industry.